Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

IOVANCE BIOTHERAPEUTICS, INC. (IOVA), most recent 12 months reported: revenue $324.97M, net loss $289.52M, free cash flow -$296.39M. Latest balance sheet on file: liquid cash $297.67M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Twist Bioscience Corporation · Immunocore Holdings plc · NOVAVAX INC · MeiraGTx Holdings plc · ADAPTIVE BIOTECHNOLOGIES CORPORATION · VERICEL CORPORATION · Vir Biotechnology, Inc. · Vaxart, Inc.

Stock screener

Watchlist